AzPA Pharmacy Flash

• FDA Approves Henlius-Organon Denosumab Biosimilars for Osteoporosis and Bone Cancer Treatment
  The U.S. FDA has approved BILDYOS and BILPREVDA, biosimilar versions of Amgen's PROLIA and XGEVA bone treatment drugs, for treating osteoporosis, glucocorticoid-induced osteoporosis and bone loss in cancer patients.
• FDA Clears CT-VQ Ventilation—Perfusion Imaging
  4DMedical's CT:VQ, the world's first noncontrast ventilation-perfusion imaging solution, has received FDA 510(k) clearance and U.S. CMS reimbursement under Category III CPT codes.
• Pharmacy Owners Say They Are Unable to Participate in MDPNP
  Pharmacy owners are considering not participating in the Medicare Drug Price Negotiation Program due to potential cashflow issues and revenue decrease.